Do you want to read an article? Please log in or register.
Outcomes of Thrombectomy in Transferred Patients With Ischemic Stroke in the Late Window: A Subanalysis From the DEFUSE 3 Trial
Stroke
RECOMMENDED
Related content
Safety and Efficacy of a 3-Dimensional Stent Retriever With Aspiration-Based Thrombectomy vs Aspiration-Based Thrombectomy Alone in Acute Ischemic Stroke Intervention: A Randomized Clinical Trial
JAMA Neurol.
Nogueira RG, Frei D, Kirmani JF, Zaidat O, Lopes D, Turk AS 3rd, Heck D, Mason B, Haussen DC, Levy EI, Mehta S, Lazzaro M, Chen M, Dörfler A, Yoo AJ, Derdeyn CP, Schwamm L, Langer D, Siddiqui A; Penumbra Separator 3D Investigators
doi: 10.1001/
RECOMMENDED
Stroke
Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
JAMA.
Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, Yan B, Bush SJ, Thijs V, Scroop R, Simpson M, Brooks M, Asadi H, Wu TY, Shah DG, Wijeratne T, Zhao H, Alemseged F, Ng F, Bailey P, Rice H, de Villiers L, Dewey HM, Choi PMC, Brown H, Redmond K, Leggett D, Fink JN, Collecutt W, Kraemer T, Krause M, Cordato D, Field D, Ma H, O'Brien B, Clissold B, Miteff F, Clissold A, Cloud GC, Bolitho LE, Bonavia L, Bhattacharya A, Wright A, Mamun A, O'Rourke F, Worthington J, Wong AA, Levi CR, Bladin CF, Sharma G, Desmond PM, Parsons MW, Donnan GA, Davis SM, EXTEND-IA TNK Part 2 investigators.
doi: 10.1001/jama.2020.1511.
Stroke
Quality of life among ischemic stroke patients eligible for endovascular treatment: analysis of the DEFUSE 3 trial
J Neurointerv Surg.
Asaithambi G, Tipps ME
doi: 10.1136/neurintsurg-2020-016399.
Stroke
Revascularization and functional outcomes after mechanical thrombectomy for acute ischemic stroke in elderly patients
J Neurosurg.
Andrews CE, Mouchtouris N, Fitchett EM, Al Saiegh F, Lang MJ, Romo VM, Herial N, Jabbour P, Tjoumakaris SI, Rosenwasser RH, Gooch MR
doi: 10.3171/2018.12.
RECOMMENDED
Stroke
Neuroimaging in Ischemic Stroke Is Different Between Men and Women in the DEFUSE 3 Cohort
★ 3
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
★ 2
Recommended by
Prof. Dr Christian Kamm, Faculty Member
Stroke.
Dula AN, Mlynash M, Zuck ND, Albers GW, Warach SJ, DEFUSE 3 Investigators.
doi: 10.1161/STROKEAHA.119.028205.
Stroke
Outcome in Direct Versus Transfer Patients in the DAWN Controlled Trial
Stroke.
Aghaebrahim A, Jadhav AP, Hanel R, Sauvageau E, Granja MF, Zhang Y, Haussen DC, Budzik RF, Bonafe A, Bhuva P, Ribo M, Cognard C, Sila C, Yavagal D, Hassan AE, Smith WS, Saver J, Liebeskind DS, Nogueira RG, Jovin TG, DAWN Investigators.
doi: 10.1161/STROKEAHA.119.025710.
Stroke
Impact of Periprocedural and Technical Factors and Patient Characteristics on Revascularization and Outcome in DAWN Trial
Stroke.
Tekle WG, Hassan AE, Jadhav AP, Haussen DC, Budzik RF, Bonafe A, Bhuva P, Yavagal DR, Hanel RA, Ribo M, Cognard C, Sila CA, Smith WS, Saver JL, Liebeskind DS, Shields R, Nogueira RG, Jovin TG, DAWN Trial Investigators.
doi: 10.1161/STROKEAHA.119.026437.
Stroke
Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial
JAMA.
Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K, Janis S, Durkalski-Mauldin VL, Neurological Emergencies Treatment Trials Network and the SHINE Trial Investigators.
doi: 10.1001/jama.2019.9346.
RECOMMENDED
Stroke
Eligibility for late endovascular treatment using DAWN, DEFUSE-3, and more liberal selection criteria in a stroke center
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
J Neurointerv Surg.
Nannoni S, Strambo D, Sirimarco G, Amiguet M, Vanacker P, Eskandari A, Saliou G, Wintermark M, Dunet V, Michel P
doi: 10.1136/neurintsurg-2019-015382.